AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 271 min read$HCA

HCA Healthcare’s (NYSE:HCA) Q3 2026: beats on revenue, stock soars

HCA Healthcare (HCA) reported Q3 2026 revenue of $19.85B, beating estimates by 3% and growing 3.6% YoY. EPS was $7.27, a 7% beat. Adjusted EBITDA reached $3.92B, a 4.9% beat. The company reconfirmed full-year revenue guidance of $78.25B but expects upper-end results. GAAP EPS and EBITDA guidance align with estimates. Free cash flow margin increased to 29.3%.

Original reporting
finance.yahoo.com
Published Oct 27, 2026, 11:19 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 11:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
HCA Healthcare’s (NYSE:HCA) Q3 2026: beats on revenue, stock soars — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$HCABullishHigh
01

Why it matters

The earnings beat and reaffirmed guidance reinforce confidence in HCA's growth trajectory, likely supporting further buying.

02

Market read

The report provides fresh, material data for a large‑cap healthcare stock, offering a clear trading catalyst.

03

What to watch

Potential cost pressures or regulatory changes not addressed in the release.

Relevance 9/10Novelty 9/10Timing: post-market

Background

HCA Healthcare is a leading U.S. hospital operator; its earnings releases are closely watched by healthcare investors.

Company-level read

Ticker impact

$HCABullishHigh confidence
Context

HCA Healthcare reported Q3 2026 revenue and earnings beats and reaffirmed full-year guidance, driving the stock higher.

Expected impact

likely upside as market prices in the earnings beat and guidance confidence

Evidence & confidence

Revenue and EPS both exceeded consensus, and guidance remains at the upper end of expectations, supporting bullish sentiment.

Market effects

Sector

Healthcare providers may see broader optimism from HCA's strong performance.

Regional

U.S. large‑cap healthcare index could receive a modest lift.

Global

Limited to U.S. markets; no direct global impact.

Counterpoint

What could challenge this read

If guidance falls short of the upper range, the stock could face a pullback.

Key entities

  • Company
    HCA Healthcare

    U.S. hospital operator (NYSE:HCA).

Read at source← All news

StoryHCA Healthcare posts Q3 2026 earnings beat, cites $400 M uninsured hit and lifts full‑year outlook

Also covered by

4 outlets

Related articles

OCT 28
$HCAMed

BofA raises HCA Healthcare stock price target on solid execution

BofA Securities raised its price target on HCA Healthcare (NYSE:HCA) to $500 from $450, citing solid execution and upside from supplemental Medicaid programs. The company's Q3 EBITDA exceeded estimates, with revenue of $19.85B and EPS of $7.22. HCA maintained its guidance range but faces near-term headwinds. The stock trades at an EV/EBITDA of 9.6x and a P/E ratio of 14.85.

investing.com2 min
OCT 27
$HCAMed

HCA Healthcare Inc (HCA) Q3 2026 Earnings Call Highlights: 22 Straight Quarters

HCA Healthcare (HCA) reported Q3 2026 earnings, highlighting a 19% decline in exchange equivalent admissions, a $400M unfavorable EBITDA impact, and reduced elective surgical volumes. The company expects $550M-$650M less in Medicaid supplemental payments in 2027. HCA anticipates 2027 earnings to be generally consistent with 2026, citing exchange headwinds and reduced supplemental payments.

finance.yahoo.com2 min
OCT 27
$HCAMedAI 8/10

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call

HCA Healthcare reported $50M in incremental Medicaid benefits in Q3, raising its 2026 estimate to $600M-$800M. Costs were flat, but professional fees rose 12%. HCA reaffirmed 2026 guidance, expecting upper-half results. For 2027, it anticipates strong demand and earnings similar to 2026. The company spent $1.36B on capital expenditures, repurchased $3B in shares, and paid $165M in dividends.

finance.yahoo.com2 min
OCT 27
$HCAHighAI 9/10

HCA (HCA) Q3 2026 Earnings Call Transcript

HCA Healthcare reported Q3 2026 revenue of $19.849 billion, up 3.6% YoY, with net income of $1.579 billion. EPS grew 4.4% to $7.27. Adjusted EBITDA rose 1.2% to $3.918 billion. Volume growth continued, but payer mix shifts impacted earnings. The company raised full-year revenue and EBITDA guidance. Management expects stable 2027 earnings despite Medicaid payment headwinds.

fool.com2 min
OCT 27
$HCAHighAI 8/10

HCA signals flat 2027 earnings as Medicaid payments drop; shares slide

HCA Healthcare forecasted flat 2027 earnings, citing lower Medicaid payments and rising uninsured patients, causing shares to drop over 5%. CEO Sam Hazen attributed the outlook to a fluid policy environment. Analysts expect 2027 EPS of $32.14, below the company's implied guidance. HCA's Q3 adjusted profit was $7.22 per share on revenue of $19.85 billion, beating estimates. The company expects 2026 EPS between $28.70 and $30.50 on revenue of $77.0B-$79.5B.

finance.yahoo.com2 min
OCT 27
$HCAMedAI 8/10

HCA Healthcare, Inc. Q3 2026 Earnings Call Summary

HCA Healthcare reported Q3 2026 volume growth of 3%, driven by demand across various service lines. The company offset payer mix pressure through higher revenue per admission and improved contract collections. Elective surgical volumes faced challenges due to federal policy changes. HCA maintained flat same-facility costs despite inflation. The company anticipates 2027 earnings to be generally consistent with 2026, with 2% to 3% volume growth.

finance.yahoo.com2 min